EPISODE · May 1, 2025 · 40 MIN
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
from Citeline Podcasts · host Norstella
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper
What this episode covers
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper
NOW PLAYING
Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m